SEC Tracker
Get the app

Carlsmed CARL

Carlsmed reports $12.25 million net loss for Q3 2026

Carlsmed (CARL) filed a 10-Q with the SEC on Nov 10, 2026, 4:11 pm ET. Source: the filing on SEC EDGAR.

Form
10-Q
Filed
Importance
Notable
  1. Revenue of $21.55 million for the three months ended Sep 30, 2026
  2. Net loss of $12.25 million for the three months ended Sep 30, 2026
  3. Diluted EPS of -$0.45 for the three months ended Sep 30, 2026

Written from the 10-Q on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when Carlsmed files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

What changed since last quarter

No new risk factors or legal mentions.

Compared with the 10-Q for the period ended Jun 30, 2026.

Key numbers from the XBRL in this filing and the previous one.
This filingPreviousChange vs prior 10-Q
Operating income and margin−$12.7M−$11.04M−15%
Net income−$12.25M−$10.51M−17%
Operating cash flow−$8.67M−$7.36M−18%
Cash$35.95M$46.24M−22%

Data on this page was fetched . The filing on SEC.gov is the record.